AIDS Vaccine Advocacy Coalition Releases Guide to Forthcoming AIDSVAX Trial Results
The AIDS Vaccine Advocacy Coalition yesterday released a guide to help policymakers, the media and the public understand the results of VaxGen's AIDSVAX trial, the first AIDS vaccine efficacy trial, which are scheduled to be released in early 2003. "Whatever the news about AIDSVAX, a highly effective, globally available vaccine against AIDS is years away," AVAC Executive Director Chris Collins said, adding, "Political leaders and the public must understand that expanded research, product development and testing, as well as stepped up efforts to make treatments and vaccines globally accessible, are critical to fighting the AIDS pandemic" (AVAC release, 10/23). The guide answers basic questions about AIDSVAX and Phase III efficacy trials and also explains what "good" versus "disappointing" trial results would mean for AIDS vaccine research ("Anticipating the News on AIDSVAX: Results from the World's First AIDS Vaccine Efficacy Trial: What Will They Mean?", AVAC, Fall 2002). The AVAC guide is available online or by request at email@example.com.This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.